Fig. 4
From: Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma
Correlation between the PMT-related risk signature and clinical and molecular features in TCGA. a The distribution of clinicopathological and molecular characteristics associated with the PMT-related 10-lncRNA signature in ascending order of risk score. b Distinct distributions of risk scores were seen among crucial factors, including WHO grade, histopathological type, molecular classification, and TCGA subtype. ****P < 0.0001; ns, non-significant. c Predictive value of the risk signature for the mesenchymal (MES) subtype was perform by ROC curve analysis in TCGA dataset. d Enrichment of the MES subtype in cases with high risk scores was verified by GSEA analysis in TCGA dataset